Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Mediators of Inflammation, enter your email address in the box below.

Mediators of Inflammation
Volume 2015 (2015), Article ID 395484, 11 pages
http://dx.doi.org/10.1155/2015/395484
Research Article

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients

Gabriella d’Ettorre,1,2 Giancarlo Ceccarelli,1,2 Mauro Andreotti,3 Carla Selvaggi,2,4 Noemi Giustini,1,2 Sara Serafino,1,2 Ivan Schietroma,1,2 Giuseppe Nunnari,5 Guido Antonelli,2,4 Vincenzo Vullo,1 and Carolina Scagnolari2,4

1Department of Public Health and Infectious Diseases, University of Rome “Sapienza”, 00185 Rome, Italy
2Pasteur Institute-Cenci Bolognetti Foundation, 00161 Rome, Italy
3Department of Therapeutic Research and Medicines Evaluation, Italian Institute of Health, 00161 Rome, Italy
4Department of Molecular Medicine, Laboratory of Virology, “Sapienza” University of Rome, 00185 Rome, Italy
5Department of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, 95122 Catania, Italy

Received 27 February 2015; Revised 7 May 2015; Accepted 21 May 2015

Academic Editor: Jianfei Yang

Copyright © 2015 Gabriella d’Ettorre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Chege, P. M. Sheth, T. Kain et al., “Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy,” AIDS, vol. 25, no. 6, pp. 741–749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Ciccone, S. W. Read, P. J. Mannon et al., “Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels,” Mucosal Immunology, vol. 3, no. 2, pp. 172–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ananworanich, A. Schuetz, C. Vandergeeten et al., “Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection,” PLoS ONE, vol. 7, no. 3, Article ID e33948, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Zaffiri, G. d'Ettorre, G. Ceccarelli et al., “Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression,” Journal of Interferon and Cytokine Research, vol. 34, no. 1, pp. 35–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Huber and J. D. Farrar, “Regulation of effector and memory T-cell functions by type I interferon,” Immunology, vol. 132, no. 4, pp. 466–474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Moschen, S. Geiger, I. Krehan, A. Kaser, and H. Tilg, “Interferon-alpha controls IL-17 expression in vitro and in vivo,” Immunobiology, vol. 213, no. 9-10, pp. 779–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Guo, E. Y. Chang, and G. Cheng, “The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice,” The Journal of Clinical Investigation, vol. 118, no. 5, pp. 1680–1690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Mogensen, J. Melchjorsen, C. S. Larsen, and S. R. Paludan, “Innate immune recognition and activation during HIV infection,” Retrovirology, vol. 7, article 54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Pillai, M. Abdel-Mohsen, J. Guatelli et al., “Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, pp. 3035–3040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Huber, H. J. Ramos, M. A. Gill, and J. D. Farrar, “Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3,” The Journal of Immunology, vol. 185, no. 2, pp. 813–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Huber, S. R. Gonzales-van Horn, K. T. Roybal, M. A. Gill, and J. D. Farrar, “IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells,” The Journal of Immunology, vol. 192, no. 12, pp. 5687–5694, 2014. View at Publisher · View at Google Scholar
  13. J. A. Kovacs, R. A. Lempicki, I. A. Sidorov et al., “Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients,” Journal of Clinical Investigation, vol. 115, no. 8, pp. 2139–2148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Monteleone, P. Di Maio, G. Cacciotti et al., “Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients,” Medical Microbiology and Immunology, vol. 203, no. 3, pp. 207–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. J. Kim, L. R. McKinnon, C. Kovacs et al., “Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation,” The Journal of Immunology, vol. 191, no. 5, pp. 2164–2173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Nigam, S. Kwa, V. Velu, and R. R. Amara, “Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection,” Journal of Immunology, vol. 186, no. 2, pp. 745–753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. d'Ettorre, S. Baroncelli, L. Micci et al., “Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial,” PLoS ONE, vol. 9, no. 10, Article ID e109791, 2014. View at Publisher · View at Google Scholar
  18. S. E. Bosinger, Q. Li, S. N. Gordon et al., “Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3556–3572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Macal, S. Sankaran, T.-W. Chun et al., “Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses,” Mucosal Immunology, vol. 1, no. 6, pp. 475–488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. George, E. Reay, S. Sankaran, and S. Dandekar, “Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration,” Journal of Virology, vol. 79, no. 5, pp. 2709–2719, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sankaran, M. Guadalupe, E. Reay et al., “Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 28, pp. 9860–9865, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Lerner, M. Guadalupe, R. Donovan et al., “The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy,” Journal of Virology, vol. 85, no. 10, pp. 4772–4782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Guadalupe, S. Sankaran, M. D. George et al., “Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection,” Journal of Virology, vol. 80, no. 16, pp. 8236–8247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Sankaran, M. D. George, E. Reay et al., “Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration,” Journal of Virology, vol. 82, no. 1, pp. 538–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese, “IFN-beta inhibits human Th17 cell differentiation,” Journal of Immunology, vol. 183, no. 8, pp. 5418–5427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese, “IFN-β1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation,” Journal of Immunology, vol. 182, no. 6, pp. 3928–3936, 2009. View at Publisher · View at Google Scholar · View at Scopus